246 related articles for article (PubMed ID: 23820312)
21. Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases.
Mishra N; Rodan LH; Nita DA; Gresa-Arribas N; Kobayashi J; Benseler SM
J Child Neurol; 2014 May; 29(5):677-83. PubMed ID: 24092895
[TBL] [Abstract][Full Text] [Related]
22. Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression.
Triplett J; Vijayan S; MacDonald A; Lawn N; McLean-Tooke A; Bynevelt M; Phatouros C; Chemmanam T
J Neuroimmunol; 2018 Oct; 323():119-124. PubMed ID: 30196824
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].
Akaishi T; Jin K; Kato K; Itabashi H; Misu T; Tateyama M; Iwasaki M; Aoki M; Nakasato N
Rinsho Shinkeigaku; 2015; 55(11):804-9. PubMed ID: 26369378
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
Solimena M; Folli F; Denis-Donini S; Comi GC; Pozza G; De Camilli P; Vicari AM
N Engl J Med; 1988 Apr; 318(16):1012-20. PubMed ID: 3281011
[TBL] [Abstract][Full Text] [Related]
25. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
Li X; Huang G; Yan X; Yang L; Zhou ZG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648
[TBL] [Abstract][Full Text] [Related]
26. Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab).
Vianello M; Giometto B; Vassanelli S; Canato M; Betterle C; Mucignat C
Exp Neurol; 2006 Dec; 202(2):514-8. PubMed ID: 16890938
[TBL] [Abstract][Full Text] [Related]
27. AUTOIMMUNE LIMBIC ENCEPHALITIS (CASE REPORTS).
Kobaidze K; Harrison A; Burklin Y; Patidar V; Riccardi M
Georgian Med News; 2017 May; (266):69-74. PubMed ID: 28628018
[TBL] [Abstract][Full Text] [Related]
28. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
[TBL] [Abstract][Full Text] [Related]
29. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
31. Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.
Lilleker JB; Biswas V; Mohanraj R
Seizure; 2014 Sep; 23(8):598-602. PubMed ID: 24836709
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
33. Antibody-mediated status epilepticus: a retrospective multicenter survey.
Holzer FJ; Rossetti AO; Heritier-Barras AC; Zumsteg D; Roebling R; Huber R; Lerche H; Kiphuth IC; Bardutzky J; Bien CG; Tröger M; Schoch G; Prüss H; Seeck M
Eur Neurol; 2012; 68(5):310-7. PubMed ID: 23051892
[TBL] [Abstract][Full Text] [Related]
34. Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.
Falip M; Rodriguez-Bel L; Castañer S; Miro J; Jaraba S; Mora J; Bas J; Carreño M
Acta Neurol Scand; 2018 Feb; 137(2):272-276. PubMed ID: 28766694
[TBL] [Abstract][Full Text] [Related]
35. Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis.
Mazzi G; Roia DD; Cruciatti B; Matà S; Catapano R
Transfus Apher Sci; 2008 Dec; 39(3):229-33. PubMed ID: 18955013
[TBL] [Abstract][Full Text] [Related]
36. Serum antibodies in epilepsy and seizure-associated disorders.
McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
[TBL] [Abstract][Full Text] [Related]
37. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings.
Baysal-Kirac L; Tuzun E; Erdag E; Ulusoy C; Vanli-Yavuz EN; Ekizoglu E; Peach S; Sezgin M; Bebek N; Gurses C; Gokyigit A; Vincent A; Baykan B
J Neurol; 2016 Mar; 263(3):455-66. PubMed ID: 26725084
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients.
Errichiello L; Perruolo G; Pascarella A; Formisano P; Minetti C; Striano S; Zara F; Striano P
J Neuroimmunol; 2009 Jun; 211(1-2):120-3. PubMed ID: 19428124
[TBL] [Abstract][Full Text] [Related]
39. Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.
Lopez-Sublet M; Bihan H; Reach G; Dupont S; Didelot A; Mourad JJ; Krivitzky A; Dhote R
Diabetes Metab; 2012 Jun; 38(3):273-5. PubMed ID: 22463975
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.
Falip M; Carreño M; Miró J; Saiz A; Villanueva V; Quílez A; Molins A; Barceló I; Sierra A; Graus F
Eur J Neurol; 2012 Jun; 19(6):827-33. PubMed ID: 22353320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
